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Introduction
The aging of the population involves a number of medical and ethical consequences. These include management of patients with multiple conditions, and of vulnerable, demented, socially isolated, and frail patients. The diverse face of aging calls for a multidisciplinary, yet individualized approach to the older person that somehow transcends the traditional nursing models. A disease process is an aspect of a multidimensional picture in which medical, functional, emotional, cognitive, and social issues are interwoven. No single provider has the competence and the expertise to address these different issues simultaneously. He or she treating the disease needs to interpret findings in the social, nutritional, and pharmacological areas with the help of specialists in these fields. This is where the need for a multidisciplinary treatment team becomes apparent. In addition, the treatment plans need to be coordinated by a person capable of implementing a complex and multidisciplinary intervention. Hence, the emergence of the nurse as a central figure in the multidisciplinary team, who is involved in assessment, treatment, and evaluation of the senior patient. Geriatrics has certainly highlighted the central role of nursing in the management of the patient. In this book we apply the principles of care of the elderly to the special problem of the older person with cancer.
Cancer is an ideal model to study elderly management for the following reasons:
Cancer is a disease of aging: 60% of all neoplasms in the USA occur in the 12% of the population aged 65 and over; Cancer is still the second most common cause of death for older individuals, and is expected to become the first, due to the decline in cardiovascular death;
Cancer is generally a chronic disease, involving a prolonged and multifaceted relationship with the provider; The management of cancer is influenced by other diseases, poor function, malnutrition, cognitive impairment, depression, social isolation: virtually all older cancer patients do benefit from a multidisciplinary intervention; Cancer affects mostly a population of so-called vulnerable elderly which is a population most likely to experience a loss of functional dependence and a decline in general health as a result of cancer and its treatment. Arguably, this is the population that benefits most from astute case management.
This book was conceived as a reference primarily for nurses and advanced practice nurses managing older patients with cancer. In addition to the practical principles relating to the prevention and the treatment of cancer in older patients, and the implementation of a multidisciplinary team, nurses and other health care providers will find an outline of urgent research issues that pertain to the care of the elderly in this book. As management of the older person is largely uncharted water, wellplanned research in geriatrics is essential to effective care.
The goal of this book is threefold. First, we want to present an overview of cancer in the elderly. In particular we want to underscore three points:
1. that cancer in the older person is more often than not preventable and treatable; 2. that a multidisciplinary team is necessary for the optimal management of the older person; 3. that the role of the nurse as case-manager needs to be contained with the role of patient advocate.
To make these points we review the epidemiology of cancer and aging, the benefits of cancer prevention and cancer treatment in the older person, the role of the multidisciplinary team, and the barriers to effective prevention and treatment. To assist practitioners in complex medical decisions, we provide a thorough description of clinical trials involving older cancer patients, a description of current guidelines for ameliorating the toxicity of chemotherapy in older individuals, a deIntroduction xi society that is rapidly evolving, the current approach to medicine is becoming obsolete. An ongoing discussion of new findings, and an ongoing exchange of experiences is the only way to translate into clinical practice new research findings, and at the same time to maintain health care that is congruent with the population it is supposed to serve. Here the time-honored nursing role of mediator between the scientific and the human aspects of medicine becomes important. The description of clinical approaches to the older patient is purposefully provocative to fuel the debate and to entreat the attention of the reader. Last, but not least, this book is the description of the personal adventure of a nurse and a physician who planned single-handedly almost nine years ago, a multidisciplinary program devoted to the treatment of the older cancer patient, within a major cancer center. At that time our approach was unique and highly controversial. The success of our collaboration is witnessed by the fact that our model is now reproduced around the country and around the world, and by the fact that the American Society of Clinical Oncology has now established a special curriculum for the management of older persons with cancer and has instituted 15 experimental fellowships in Geriatric Oncology. We hope we are not the best, because we wish to see a progressive improvement in this important field, but we certainly have been the first. We feel it is only fair to share with our readers our sense of accomplishment that includes a deeply felt and lasting friendship.
We wish to thank the persons who have been the main participants in our endeavor: Anita Klamo, the program secretary, has been since the very beginning the soul of the program. Kathy Effingham, RN, Carolyn Kline, RN, and Paulette Daniels, RN, and her predecessor Margaret Bina, RN, have mostly inspired this book thanks to the compassionate care they have provided. Julie Meyer, the ARPN who recently joined the program has become an example of care coordinator; Martine Extermann, MD, PhD, who has joined us from Switzerland, has become the director of the program for innovative research; Margaret McGinnis, MSW has provided invaluable assistance both to our patients and to our research plans; Theresa Thomasewski, RD has provided a continuous, reliable, and highly appreciated dietary assessment of the older persons with cancer; and Mary Beth Corcoran, the program pharmacist, has fought harder than anybody the plague of polypharmacy. And, most of all, we'd like to thank the thousands of patients who have walked through our program and to whom this book is dedicated. "I stopped by before work so I could be the first to congratulate you on such a momentous day," exclaimed Mary as she released her mother from a vigorous hug.
"Thanks, but I haven't heard anything yet this morning. The attorney is probably not in the office yet, " replied Kathy flatly. "Just think, after three years of hell everything will be final today. You will get closure on this whole ordeal," said Mary as she took off her sunglasses, turning her face to the rising morning sun. "So mom, would you like to get something to eat after I get home tonight? I shouldn't be too late and we could go to Bert's and get a burger." "No, I'm going to play cards with the girls tonight, but I can go tomorrow," replied Kathy, thinking about how much she enjoyed her card games with Sarah, Kim, and Carol. "OK, well, I'll call later," muttered Mary, looking a little hurt as she jumped back into her car and started the engine.
Mary spun down the drive. Kathy watched after her, already beginning to regret her decision. She thought as she turned to open the front door, "I've spent my life worrying, protecting, and loving my family. Today I start to live for myself."
The phone was ringing as Kathy walked across the cool living room. "Hello," answered Kathy while looking at her calendar, realizing she had made dinner plans for tomorrow night with girls from the literary club.
"Hello, Mrs. Clark?" said a vaguely familiar voice. "Yes," responded Kathy, thinking that she would have to break her plans with the girls tomorrow and go out with Mary. "This is Catherine Phillips, the nurse from Dr. Tate's office. A small abnormality was found on your mammogram yesterday, and we would like you to come in so we can rule out any problems."
"OK, what kind of problems? asked Kathy, knowing full well the kind of problems to which the young nurse was referring. Kathy had many friends that had been diagnosed with various forms of cancer. She had frequently fantasized how she would handle such an insult to her health. "Well, Mrs. Clark, whenever an abnormality is discovered on a mammogram, further testing must be performed to detect breast cancer. Most likely the spot is nothing, but we would like you to come in and have us check it out. Can you come in today?" asked Ms. Phillips. "Sure," replied Kathy involuntarily. "Let's get this over with so I don't worry about this for nights on end." "We have an opening at 2:00?" "That would be fine." Kathy put down the phone and fed the cats. She began telling herself, that worrying was not going to help. "I just survived an awful divorce. I guess I can survive anything." Kathy had always maintained her calm in a crisis. Historically, she had silently dealt with previous hardships and crises as times or events to move through, not to be belabored with heightened anxiety or emotion. The door opened and Mary appeared looking as beautiful as ever, her abdomen filling her maternity blouse. "Guess what, mom?" Mary asked, smiling broadly. "I got my promotion and they're transferring me to Florida! It will only be for a little while, but I'm very excited. Did you hear anything from the attorney? "Yes, everything is final. Finally," replied Kathy.
Dr
"Well, you don't sound too happy." "I am. I'm just tired," said Kathy as she picked up her keys and led the way out the door.
As they reached the restaurant, Mary chatted about her job and her upcoming move.
"Oh, mom, things are beginning to look up for us. You are a free woman, and I am moving on with my career! Let's order something sinful, with lots of chocolate!" Dinner proceeded, with Mary continuously chirping about various issues, mostly concerning her work and her friends. Dessert came and Mary noticed that her mother had been uncharacteristically quiet and didn't even eat much of her dinner.
"Mom, what's wrong? You've been quiet all night." "Mary, I had a breast biopsy yesterday, and the doctor has found cancer," said Kathy in a very calm, matter-of-fact voice. 
CHAPTER ONE
Epidemiology and Pathology of Cancer and Aging
Janine Overcash and Lodovico Balducci his chapter reviews the epidemiology of cancer in the elderly. Epidemiology represents an opportunity to pursue the following:
To illustrate the extent and scope of the problem; To explain that reduction in cancer-related morbidity and mortality in the older person is paramount to cancer control; To explore the biological mechanisms linking age and cancer, and the possibility of preventative interventions; To describe a profile of the older person with cancer. This profile will demonstrate that the benefits of cancer prevention and cancer treatment generally overwhelm the risks, even in the aged.
THE CHANGING DEMOGRAPHIC LANDSCAPE
The average life expectancy in the United States has been progressively increasing (Table 1 .1), while at the same time the birth rate has declined (National Center for Health Statistics, 1991). The combination of these events has led to a phenomenon known by demographers as "squaring of the pyramid" (Figure 1.1) (Yancik & Ries, 1998) . At the beginning of the century, a graphic description of the population of the USA (and of the other Western countries) appeared as a pyramid, with a large base of persons under 20 and a small top of persons over 65. In 1990, the picture looked more like a trapezoid, 9 T 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 1973 1972 1971 1970 1969 1968 1967 1966 1965 1964 1954 1953 1952 1951 1950 1949 1948 1947 1946 1945 1944 1943 1942 1941 1940 1939 1938 1937 1936 1935 1934 1933 1932 with a larger top and a smaller base. If this trend continues, one may expect that one third of the US population will be aged 65 and over by the year 2000 (Yancik & Ries, 2000) . Of special concern to health care operators is the fact that the population increasing more rapidly is aged 85 and older, the so-called "oldest old" (Kennedy, 1993) , arguably the population most in need of health and supportive care. The expansion of the older population has led to new clinical problems related to a concentration of chronic diseases among the elderly. The focus of this chapter is cancer, but the problems related to cancer are common to other conditions as well and concern the following:
Causes of the association of chronic diseases and aging; Biology of chronic disease in the older person, especially for what concerns the influence of multiple comorbidities (Fried, Storer, King, & Lodder, 1991; Hammermann et al., 1999; Yancik, et al. 2001) ; Management-related problems related to both prevention and treatment. In particular, in cancer prevention and cancer treatment, the benefits of the intervention may be fewer, due to decreased life expectancy, and the risks higher, due to a reduction in functional reserve (Balducci & Extermann, 2001 ).
Goals of prevention and treatment often reflect a popular outcome alternative to prolongation of survival, which is compression of morbidity (Crimmins & Saito, 2001 ). This construct stems from two considerations. First, human life span (that is, the time each person is programmed to live, irrespective of external factors, such as diseases, accidents, or wars), is limited. Second, after age 40, disease and disability precede death for an average of 30 and 20 years, respectively (Table 1. 2). Hence, the most reasonable goal of health interventions in the older person may be reducing the time gap between disease, disability, and death. In other words, one can say that preservation of function and quality of life may be a more realistic goal than cure of the disease in the older person.
ASSOCIATION OF CANCER AND AGE: MECHANISMS AND CLINICAL IMPLICATIONS
The incidence of most common cancer increases with age (Table 1 . 2); currently approximately 50% of all malignancies occur in persons aged 65 and older; by the year 2030, this proportion may rise to 60% due to the expansion of the older population (Yancik & Ries, 2000) . Together with the incidence of cancer, (ACS,2001 ) the prevalence of cancer may also increase with age (Verdecchia et al., 2001) . A number of factors may contribute to the increased prevalence of cancer. In addition to the increased incidence, probably the fact that common cancers, such as breast and lung cancer, generally have a more indolent course in older individuals, and the survival of these individuals with metastatic cancer may be longer, explains the increased prevalence (Crimmins & Saito, 2001) . Also, prostate cancer, which affects mostly older men, is associated with many years of survival and accounts for the higher prevalence of cancer among the elderly. Cancer is currently a common cause of death in individuals over 65, second only to cardiovascular diseases (Anisimov, 1998) . Of interest, death rate from cardiovascular diseases is declining among the elderly, however, probably as a consequence of smoking cessation, improved diet, and more frequent exercise, whereas death rate from cancer has remained constant or has slightly increased, however hypertension remains the leading cause of death (Figure 1.2) (Lavecchia, 2001) . It is reasonable to expect that cancer may become the first cause of death during the next two decades.
The association of cancer and aging may be explained by three nonmutually exclusive mechanisms. Carcinogenesis, the process leading to the formation of clinical cancer from a normal cell, is time consuming. Though it is impossible to calculate precisely the carcinogenic time of human cancer, it is reasonable to think that in some cases it may approach 20 or more years (Fernandez-Pol & Douglas, 2001; Minton & Shaw, 1998 ). It is not surprising then to find the highest concentration of cancer in older individuals.
Carcinogenesis involves a number of serial steps that must occur in a precise order to produce cancer (Fernandez-Pol & Douglas, 2001 ). steps involve the activation of oncogenes or the suppression in the activity of anti-proliferative genes (antioncogenes), which are acted upon by substances called "early-stage carcinogens" and are considered irreversible. The subsequent steps may involve the release of substances that stimulate tumor growth, are effected by "late-stage carcinogens" and may be reversible. Chemoprevention of cancer acts primarily by reversing the late carcinogenic steps (Balducci & Beghe, 2000; Hong, Spiz & Lippman, 2000; Minton & Shaw, 1998) . Preponderant evidence suggests that aging cells may be in an advanced carcinogenic status and thus more susceptible to late stage carcinogens. In cell cultures, some molecular changes of aging, including formation of DNA adducts, DNA hypomethylation, point mutations, and DNA translocation, mimic the changes of early carcinogenic steps. In addition, the tissues of older animals, including the cutaneous, the lymphatic, the hepatic, and the nervous tissues, are more likely to develop cancer when exposed to late-stage carcinogens than are those of younger animals (Anisimov, 2001; Anisimov et al., 2001) .
Several lines of circumstantial evidence suggest that the tissues of aging humans may also be primed to the effects of late-stage carcinogens. The incidence of non-melanomatous skin cancer and of prostate cancer (Balducci et al., 1997) increases logarithmically with age, which suggests increased susceptibility of older persons to these types of cancer. The incidence of non-Hodgkin's lymphoma increased 80% in people over 60 between 1970 and 1990 (Monfardini & Carbone, 1998 and that of malignant brain tumors has increased 700/6, or sevenfold, in persons aged 70 and older (Flowers, 1998) . This increment, which concerns older individuals exclusively, suggests that these individuals may be more susceptible to new environmental carcinogens. Perhaps the most convincing demonstration of this enhanced susceptibility comes from an unfortunate natural experiment that occurred in the early 1970s in the Eastern Italian town of Trieste, when a leak of dioxin affected the whole town. Fifteen years later it was found that the risk of lung cancer from dioxin was more than twice as high for persons who were over 70 at the time of exposure than for those who were under 50 (Barbone et al., 1995) .
The aging biological environment may also favor carcinogenesis. Paradoxically, proliferative senescence may be one of these factors (Campisi, 1997) . This finding is counterintuitive, because proliferative senescence implies the loss of a cell's ability to replicate itself. However, the senescent cells may lose in the meantime the ability to undergo programmed cell death (apoptosis), and consequently their population may continue to grow even if the proliferative rate is decreased. This is one of the mechanisms of indolent small lymphocytic follicular lymphoma, whose cells over-express an abnormal form of Bcl2, which prevents apoptosis (Cotter, Waters & Cunningham, 1999; Warner, 1997) . In addition, the senescent cells may favor the growth and spreading of tumors in surrounding tissues. Proliferative senescence is associated with increased production of heregulin, a powerful tumor growth factor, and of metalloproteinases, which dissolve the basal membranes of tissues (Campisi, 1997) . Immune-senescence implies a progressive loss in cell-mediated immunity (Burns & Goodwin, 1998) , an important natural bulwark against tumor growth.
The increased susceptibility of older persons to environmental carcinogens has important clinical consequences. First, it overturns a widely held tenet that primary prevention of cancer is futile in older individuals, because all carcinogenic changes have already occurred. It suggests instead that removal of environmental carcinogens, such as smoking cessation, may be mostly beneficial to older individuals. Second, it suggests that older individuals may be prime candidates for chemoprevention, which prevents and reverses late carcinogenic steps (Hong, Spits, & Lippman, 2000) .
THE PROFILE OF THE OLDER PERSON WITH CANCER
The critical question in geriatric oncology is whether older individuals die with cancer or of cancer. The answer determines whether can-cer prevention and cancer treatment in older individuals are worthwhile goals. Diab et al. (2000) compared the survival of breast cancer patients and that of women without breast cancer of the same age, using the SEER (Surveillance, Epidemiology and End Results) database. It was found that breast cancer was associated with lower life expectancy in women aged 50 to 65, but did not affect the survival of those aged 70 to 75. For those over 80, survival tended to increase. The most likely explanation of these findings is that the general health of older women with breast cancer is better than that of the whole population of women approximately the same age. This study confirms previous observations by other authors, in that Repetto et al. (1998) found that the incidence of comorbidity and functional dependence was lower among patients aged 65 and older with cancer than among age-matched controls of the same age. Ferrucci (1998) compared the functional status and comorbidity of all cancer patients aged 65 and older and persons of the same age in the small Italian town of Cusumano, and found that cancer patients had an overall better health condition (Ferrucci, L; Personal Communication, Fourth International Conference of Geriatric Oncology, Sheraton Hoelt, Rome, Italy, October 1998). Stanta et al. (1997) found that the prevalence of comorbidity at autopsy was lower among cancer patients aged 70 to 95 than among aged-matched controls without cancer. On this basis, it is reasonable to assume that cancer is the cause of death for a large portion, perhaps the majority of older cancer patients, and cancer control is highly worthwhile for these individuals (Stanta et al., 1997) .
The fact that cancer should develop preferentially in healthy and independent older individuals is not clear, but reasonable speculations may be made based on recent insights in the biology of aging. Aging is associated with a progressive accumulation in the circulation of catabolic cytokines, including interleukin-6 and tumor necrosis factor (Balducci & Extermann 2001) . Seemingly, these cytokines, which are a chemical hallmark of frail elderly, may oppose tumor growth. Even the dysfunction of the immune system due to aging may act as a two-edged sword, and in some cases, it may inhibit tumor growth (Hurz et al., 1990) . A number of other environmental changes characteristic of frail elderly include reduced production of growth hormone and consequently of insulin-like growth factor 1 ( IGF-1), one of the most powerful tumor growth factors (Rosen, 2000) .
CONCLUSIONS
Clearly, cancer will become mostly a disease of older individuals, if the current demographic trend continues. The association of cancer and aging may be accounted for by the length of time of carcinogenesis, by molecular changes of aging that prime the older tissue to the effects of latestage carcinogens, and by a number of age-related environmental changes that favor cancer growth. Those factors that make older individuals more susceptible to cancer may partly be reversed by elimination of environmental carcinogens and by chemoprevention. Cancer is mostly a disease of healthy and functional elderly, whose survival may be shortened and whose quality of life may be deranged by cancer. Cancer prevention and cancer treatment appear highly worthwhile in older individuals.
